Bronte Capital Management Pty Ltd. lessened its position in shares of Herbalife Ltd. (NYSE:HLF - Free Report) by 39.7% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 1,599,168 shares of the company's stock after selling 1,054,746 shares during the quarter. Herbalife makes up about 1.6% of Bronte Capital Management Pty Ltd.'s holdings, making the stock its 10th largest position. Bronte Capital Management Pty Ltd. owned about 1.59% of Herbalife worth $10,698,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also made changes to their positions in the company. Perpetual Ltd raised its stake in Herbalife by 107.1% in the 4th quarter. Perpetual Ltd now owns 966,063 shares of the company's stock valued at $6,463,000 after purchasing an additional 499,572 shares during the last quarter. Hotchkis & Wiley Capital Management LLC raised its stake in Herbalife by 20.2% in the 3rd quarter. Hotchkis & Wiley Capital Management LLC now owns 2,287,600 shares of the company's stock valued at $16,448,000 after purchasing an additional 384,100 shares during the last quarter. Iridian Asset Management LLC CT raised its stake in Herbalife by 12.5% in the 4th quarter. Iridian Asset Management LLC CT now owns 2,507,740 shares of the company's stock valued at $16,777,000 after purchasing an additional 279,547 shares during the last quarter. Charles Schwab Investment Management Inc. raised its stake in Herbalife by 8.7% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 2,696,560 shares of the company's stock valued at $18,040,000 after purchasing an additional 216,603 shares during the last quarter. Finally, Jacobs Levy Equity Management Inc. increased its stake in shares of Herbalife by 15.5% during the 3rd quarter. Jacobs Levy Equity Management Inc. now owns 1,539,148 shares of the company's stock valued at $11,066,000 after acquiring an additional 206,530 shares during the last quarter.
Analysts Set New Price Targets
Separately, DA Davidson reaffirmed a "neutral" rating and set a $7.50 price objective on shares of Herbalife in a research note on Thursday, February 20th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and three have issued a buy rating to the company's stock. Based on data from MarketBeat, Herbalife has a consensus rating of "Hold" and a consensus price target of $9.90.
View Our Latest Report on HLF
Insider Transactions at Herbalife
In other news, Director Juan Miguel Mendoza bought 5,000 shares of the stock in a transaction that occurred on Thursday, February 27th. The shares were purchased at an average cost of $8.25 per share, with a total value of $41,250.00. Following the completion of the acquisition, the director now directly owns 132,500 shares in the company, valued at approximately $1,093,125. The trade was a 3.92 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 0.94% of the company's stock.
Herbalife Trading Down 4.7 %
HLF stock opened at $8.50 on Wednesday. The firm has a market cap of $859.67 million, a P/E ratio of 3.41, a P/E/G ratio of 0.29 and a beta of 1.02. Herbalife Ltd. has a 12-month low of $5.04 and a 12-month high of $12.79. The stock's 50 day simple moving average is $6.73 and its 200 day simple moving average is $7.21.
Herbalife (NYSE:HLF - Get Free Report) last issued its earnings results on Wednesday, February 19th. The company reported $0.36 earnings per share for the quarter, topping the consensus estimate of $0.08 by $0.28. Herbalife had a negative return on equity of 20.78% and a net margin of 5.09%. The firm had revenue of $1.21 billion for the quarter, compared to analyst estimates of $1.19 billion. On average, research analysts forecast that Herbalife Ltd. will post 1.57 EPS for the current fiscal year.
Herbalife Profile
(
Free Report)
Herbalife Ltd. provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers products in the areas of weight management; targeted nutrition; energy, sports, and fitness; outer nutrition; and literature and promotional items.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Herbalife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Herbalife wasn't on the list.
While Herbalife currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
